Selected research
Industry Research
Perennial Allergic Rhinitis Drug Industry Research Report 2026
Market perspective
The global Perennial Allergic Rhinitis Drug market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Perennial Allergic Rhinitis Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Perennial Allergic Rhinitis Drug is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Perennial Allergic Rhinitis Drug is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Perennial Allergic Rhinitis Drug include Merck & Co., Inc., Pfizer Inc., VentiRx Pharmaceuticals, Inc., Shionogi & Co., Ltd., Hisamitsu Pharmaceutical Co., Inc., Glenmark Pharmaceuticals Ltd. and Faes Farma, S.A., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Perennial Allergic Rhinitis Drug market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Perennial Allergic Rhinitis Drug Market by Company
Merck & Co., Inc.
Pfizer Inc.
VentiRx Pharmaceuticals, Inc.
Shionogi & Co., Ltd.
Hisamitsu Pharmaceutical Co., Inc.
Glenmark Pharmaceuticals Ltd.
Faes Farma, S.A.
Perennial Allergic Rhinitis Drug Segment by Type
APC-3000
Bilastine
Desloratadine
Asapiprant
Others
Perennial Allergic Rhinitis Drug Segment by Application
Clinic
Hospital
Others
Perennial Allergic Rhinitis Drug Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Perennial Allergic Rhinitis Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Perennial Allergic Rhinitis Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Perennial Allergic Rhinitis Drug.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Perennial Allergic Rhinitis Drug manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Perennial Allergic Rhinitis Drug by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Perennial Allergic Rhinitis Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- APC-3000
- Bilastine
- Desloratadine
- Asapiprant
- Others
Applications
- Clinic
- Hospital
- Others
Companies covered
- Merck & Co., Inc.
- Pfizer Inc.
- VentiRx Pharmaceuticals, Inc.
- Shionogi & Co., Ltd.
- Hisamitsu Pharmaceutical Co., Inc.
- Glenmark Pharmaceuticals Ltd.
- Faes Farma, S.A.
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Perennial Allergic Rhinitis Drug Market Size (2021-2032)
- 2.2.2 Global Perennial Allergic Rhinitis Drug Sales (2021-2032)
- 2.2.3 Global Perennial Allergic Rhinitis Drug Market Average Price (2021-2032)
- 2.3 Perennial Allergic Rhinitis Drug by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 APC-3000
- 2.3.3 Bilastine
- 2.3.4 Desloratadine
- 2.3.5 Asapiprant
- 2.3.6 Others
- 2.4 Perennial Allergic Rhinitis Drug by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Clinic
- 2.4.3 Hospital
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Perennial Allergic Rhinitis Drug Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Perennial Allergic Rhinitis Drug Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Perennial Allergic Rhinitis Drug Revenue of Manufacturers (2021-2026)
- 3.4 Global Perennial Allergic Rhinitis Drug Average Price by Manufacturers (2021-2026)
- 3.5 Global Perennial Allergic Rhinitis Drug Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Perennial Allergic Rhinitis Drug, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Perennial Allergic Rhinitis Drug, Product Type & Application
- 3.8 Global Manufacturers of Perennial Allergic Rhinitis Drug, Established Date
- 3.9 Global Perennial Allergic Rhinitis Drug Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Merck & Co., Inc.
- 4.1.1 Merck & Co., Inc. Company Information
- 4.1.2 Merck & Co., Inc. Business Overview
- 4.1.3 Merck & Co., Inc. Perennial Allergic Rhinitis Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Merck & Co., Inc. Perennial Allergic Rhinitis Drug Product Portfolio
- 4.1.5 Merck & Co., Inc. Recent Developments
- 4.2 Pfizer Inc.
- 4.2.1 Pfizer Inc. Company Information
- 4.2.2 Pfizer Inc. Business Overview
- 4.2.3 Pfizer Inc. Perennial Allergic Rhinitis Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Pfizer Inc. Perennial Allergic Rhinitis Drug Product Portfolio
- 4.2.5 Pfizer Inc. Recent Developments
- 4.3 VentiRx Pharmaceuticals, Inc.
- 4.3.1 VentiRx Pharmaceuticals, Inc. Company Information
- 4.3.2 VentiRx Pharmaceuticals, Inc. Business Overview
- 4.3.3 VentiRx Pharmaceuticals, Inc. Perennial Allergic Rhinitis Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 VentiRx Pharmaceuticals, Inc. Perennial Allergic Rhinitis Drug Product Portfolio
- 4.3.5 VentiRx Pharmaceuticals, Inc. Recent Developments
- 4.4 Shionogi & Co., Ltd.
- 4.4.1 Shionogi & Co., Ltd. Company Information
- 4.4.2 Shionogi & Co., Ltd. Business Overview
- 4.4.3 Shionogi & Co., Ltd. Perennial Allergic Rhinitis Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Shionogi & Co., Ltd. Perennial Allergic Rhinitis Drug Product Portfolio
- 4.4.5 Shionogi & Co., Ltd. Recent Developments
- 4.5 Hisamitsu Pharmaceutical Co., Inc.
- 4.5.1 Hisamitsu Pharmaceutical Co., Inc. Company Information
- 4.5.2 Hisamitsu Pharmaceutical Co., Inc. Business Overview
- 4.5.3 Hisamitsu Pharmaceutical Co., Inc. Perennial Allergic Rhinitis Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Hisamitsu Pharmaceutical Co., Inc. Perennial Allergic Rhinitis Drug Product Portfolio
- 4.5.5 Hisamitsu Pharmaceutical Co., Inc. Recent Developments
- 4.6 Glenmark Pharmaceuticals Ltd.
- 4.6.1 Glenmark Pharmaceuticals Ltd. Company Information
- 4.6.2 Glenmark Pharmaceuticals Ltd. Business Overview
- 4.6.3 Glenmark Pharmaceuticals Ltd. Perennial Allergic Rhinitis Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Glenmark Pharmaceuticals Ltd. Perennial Allergic Rhinitis Drug Product Portfolio
- 4.6.5 Glenmark Pharmaceuticals Ltd. Recent Developments
- 4.7 Faes Farma, S.A.
- 4.7.1 Faes Farma, S.A. Company Information
- 4.7.2 Faes Farma, S.A. Business Overview
- 4.7.3 Faes Farma, S.A. Perennial Allergic Rhinitis Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Faes Farma, S.A. Perennial Allergic Rhinitis Drug Product Portfolio
- 4.7.5 Faes Farma, S.A. Recent Developments
5 Global Perennial Allergic Rhinitis Drug Market Scenario by Region
- 5.1 Global Perennial Allergic Rhinitis Drug Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Perennial Allergic Rhinitis Drug Sales by Region: 2021-2032
- 5.2.1 Global Perennial Allergic Rhinitis Drug Sales by Region: 2021-2026
- 5.2.2 Global Perennial Allergic Rhinitis Drug Sales by Region: 2027-2032
- 5.3 Global Perennial Allergic Rhinitis Drug Revenue by Region: 2021-2032
- 5.3.1 Global Perennial Allergic Rhinitis Drug Revenue by Region: 2021-2026
- 5.3.2 Global Perennial Allergic Rhinitis Drug Revenue by Region: 2027-2032
- 5.4 North America Perennial Allergic Rhinitis Drug Market Facts & Figures by Country
- 5.4.1 North America Perennial Allergic Rhinitis Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Perennial Allergic Rhinitis Drug Sales by Country (2021-2032)
- 5.4.3 North America Perennial Allergic Rhinitis Drug Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Perennial Allergic Rhinitis Drug Market Facts & Figures by Country
- 5.5.1 Europe Perennial Allergic Rhinitis Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Perennial Allergic Rhinitis Drug Sales by Country (2021-2032)
- 5.5.3 Europe Perennial Allergic Rhinitis Drug Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Perennial Allergic Rhinitis Drug Market Facts & Figures by Country
- 5.6.1 Asia Pacific Perennial Allergic Rhinitis Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Perennial Allergic Rhinitis Drug Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Perennial Allergic Rhinitis Drug Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Perennial Allergic Rhinitis Drug Market Facts & Figures by Country
- 5.7.1 South America Perennial Allergic Rhinitis Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Perennial Allergic Rhinitis Drug Sales by Country (2021-2032)
- 5.7.3 South America Perennial Allergic Rhinitis Drug Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Perennial Allergic Rhinitis Drug Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Perennial Allergic Rhinitis Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Perennial Allergic Rhinitis Drug Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Perennial Allergic Rhinitis Drug Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Perennial Allergic Rhinitis Drug Sales by Type (2021-2032)
- 6.1.1 Global Perennial Allergic Rhinitis Drug Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Perennial Allergic Rhinitis Drug Sales Market Share by Type (2021-2032)
- 6.2 Global Perennial Allergic Rhinitis Drug Revenue by Type (2021-2032)
- 6.2.1 Global Perennial Allergic Rhinitis Drug Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Perennial Allergic Rhinitis Drug Revenue Market Share by Type (2021-2032)
- 6.3 Global Perennial Allergic Rhinitis Drug Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Perennial Allergic Rhinitis Drug Sales by Application (2021-2032)
- 7.1.1 Global Perennial Allergic Rhinitis Drug Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Perennial Allergic Rhinitis Drug Sales Market Share by Application (2021-2032)
- 7.2 Global Perennial Allergic Rhinitis Drug Revenue by Application (2021-2032)
- 7.2.1 Global Perennial Allergic Rhinitis Drug Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Perennial Allergic Rhinitis Drug Revenue Market Share by Application (2021-2032)
- 7.3 Global Perennial Allergic Rhinitis Drug Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Perennial Allergic Rhinitis Drug Value Chain Analysis
- 8.1.1 Perennial Allergic Rhinitis Drug Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Perennial Allergic Rhinitis Drug Production Mode & Process
- 8.2 Perennial Allergic Rhinitis Drug Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Perennial Allergic Rhinitis Drug Distributors
- 8.2.3 Perennial Allergic Rhinitis Drug Customers
9 Global Perennial Allergic Rhinitis Drug Analyzing Market Dynamics
- 9.1 Perennial Allergic Rhinitis Drug Industry Trends
- 9.2 Perennial Allergic Rhinitis Drug Industry Drivers
- 9.3 Perennial Allergic Rhinitis Drug Industry Opportunities and Challenges
- 9.4 Perennial Allergic Rhinitis Drug Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst